Los Angeles, CA, United States of America

Kresna Hartandi



 

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 101(Granted Patents)


Location History:

  • Gurnee, IL (US) (2003 - 2004)
  • Los Angeles, CA (US) (2007 - 2011)
  • Belmont, CA (US) (2012 - 2015)

Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Kresna Hartandi: Innovator in Kinase Inhibitors

Introduction

Kresna Hartandi is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of biochemistry, particularly in the development of kinase inhibitors. With a total of 9 patents to his name, Hartandi's work has the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents are the indazole, benzisoxazole, and benzisothiazole kinase inhibitors. These compounds are designed to inhibit protein tyrosine kinases, which play a crucial role in cell signaling and cancer progression. The patents also disclose methods for synthesizing these compounds, as well as compositions containing them and methods of treatment utilizing these innovative compounds.

Career Highlights

Kresna Hartandi has worked with notable companies in the pharmaceutical industry, including Abbott Laboratories Corporation and AbbVie Inc. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Throughout his career, Hartandi has collaborated with talented individuals such as Yujia Dai and Michael Michaelides. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Kresna Hartandi is a distinguished inventor whose work in kinase inhibitors showcases his commitment to advancing medical science. His innovative contributions continue to pave the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…